Trial Profile
A Multi-center, Double-masked, Randomized, Placebo-controlled, Parallel-group Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy, Normal Volunteers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Sep 2020
Price :
$35
*
At a glance
- Drugs Ketotifen/naphazoline (Primary)
- Indications Allergic conjunctivitis
- Focus Adverse reactions; Registrational
- Sponsors Bausch & Lomb
- 27 Nov 2015 New trial record